Brief: Metavia Builds Comprehensive Global Patent Protection For Da-1726, Securing Exclusive Rights To Novel Obesity And Metabolic Therapy
13/02/2026 14:25
Feb 13 (Reuters) - MetaVia Inc MTVA.O: METAVIA BUILDS COMPREHENSIVE GLOBAL PATENT PROTECTION FOR DA-1726, SECURING EXCLUSIVE RIGHTS TO NOVEL OBESITY AND METABOLIC THERAPY THROUGH 2041 Source text: ID:nPn2FgBqha Further company coverage: MTVA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MetaVia
See all newsMetaVia Inc reports results for the quarter ended June 30 - Earnings Summary
MetaVia Q2 net loss widens on higher R&D spending
MetaVia Inc expected to post a loss of 82 cents a share - Earnings Preview
Brief: Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors
MetaVia Q1 net loss widens slightly as expenses rise